Merck & Co’s Keytruda produces mixed results in SCLCMerck & Co’s Keytruda immunotherapy has produced mixed results in a phase 3 trial testing it in first-line Share XMerck & Co’s Keytruda produces mixed results in SCLChttps://pharmaphorum.com/news/merck-cos-keytruda-produces-mixed-results-in-sclc/
MiNA’s gene-activating tech wins an AstraZeneca allianceUK biotech MiNA Therapeutics’ RNA-based gene-activating technology has caught the eye of big pharma AstraZeneca. AZ has teamed Share XMiNA’s gene-activating tech wins an AstraZeneca alliancehttps://pharmaphorum.com/news/minas-gene-activating-tech-wins-an-astrazeneca-alliance/
PharmaLex merges with CompliMedPharmaLex Group has completed its merger with CompliMed in the United Kingdom. CompliMed is the UK’s leading Healthcare Share XPharmaLex merges with CompliMedhttps://pharmaphorum.com/sales-marketing/pharmalex-merges-with-complimed/
Merck & Co joins KRAS gold rush with Taiho and Astex collaborationUS-based Merck & Co has forged an R&D tie-up with Taiho and Astex Pharmaceuticals, focused on developing small Share XMerck & Co joins KRAS gold rush with Taiho and Astex collaborationhttps://pharmaphorum.com/news/merck-co-joins-kras-gold-rush-with-taiho-and-astex-collaboration/
Transgene starts trials of ‘digital’ cancer vaccine with NECUndeterred by two clinical failures for its cancer immunotherapies in 2019, Transgene has kicked off the New Year Share XTransgene starts trials of ‘digital’ cancer vaccine with NEChttps://pharmaphorum.com/news/transgene-starts-trials-of-digital-cancer-vaccine-with-nec/
Pfizer/Merck KGaA’s Bavencio set for bladder cancer advantage after phase 3 winPfizer and German Merck can breathe a sigh of relief after a phase 3 trial confirmed that their Share XPfizer/Merck KGaA’s Bavencio set for bladder cancer advantage after phase 3 winhttps://pharmaphorum.com/news/pfizer-merck-kgaas/
KRY raises $155 million to develop and grow digital doctor appEuropean digital doctor app KRY has raised $155 million to help accelerate its growth plans across the continent Share XKRY raises $155 million to develop and grow digital doctor apphttps://pharmaphorum.com/news/kry-raises-155-million-to/
Black Diamond becomes first biotech to announce IPO in 2020Black Diamond Therapeutics has become the first biotech to announce an IPO in 2020, asking investors to fund Share XBlack Diamond becomes first biotech to announce IPO in 2020https://pharmaphorum.com/news/black-diamond-becomes-first-biotech-to-announce-ipo-in-2020/
AstraZeneca kicks off 2020 with double win in US and ChinaAstraZeneca has started 2020 strongly, with the FDA granting a fast review for its big-selling Farxiga in heart Share XAstraZeneca kicks off 2020 with double win in US and Chinahttps://pharmaphorum.com/news/astrazeneca-kicks-off-2020-with-double-win-in-us-and-china/
